Increase of widespread A, B1 and D Escherichia coli clones producing a high diversity of CTX-M-types in a Portuguese hospital

Future Microbiology

Volumn 10, Issue 7, 2015, Pages 1125-1131

  Rodrigues, Carla ^a   Machado, Elisabete ^a,b   Pires, João ^a   Ramos, Helena ^c   Novais, Angela ^a   Peixe, Luísa ^a  

^a UNIVERSITY OF PORTO   (Portugal)

^b UNIVERSIDADE FERNANDO PESSOA   (Portugal)

^c HOSPITAL DE SANTO ANTÓNIO   (Portugal)

Author keywords

ESBL; MLST; nonclinical reservoirs; phylogenetic group; widespread clonal complexes

Indexed keywords

BETA LACTAMASE CTX M; BETA LACTAMASE SHV; EXTENDED SPECTRUM BETA LACTAMASE; BETA LACTAMASE; BETA-LACTAMASE CTX-M, E COLI; BETA-LACTAMASE SHV-12; BETA-LACTAMASE TEM-3; ESCHERICHIA COLI PROTEIN;

ARTICLE; BACTERIUM ISOLATE; CLONE; ESCHERICHIA COLI; GENE AMPLIFICATION; GENE IDENTIFICATION; HOSPITAL; NONHUMAN; PHYLOGENY; PORTUGAL; PRIORITY JOURNAL; BIOSYNTHESIS; ENZYMOLOGY; ESCHERICHIA COLI INFECTIONS; GENETICS; GENOTYPE; HUMAN; ISOLATION AND PURIFICATION; MICROBIAL SENSITIVITY TEST; MICROBIOLOGY; MOLECULAR EPIDEMIOLOGY; MULTILOCUS SEQUENCE TYPING; PULSED FIELD GEL ELECTROPHORESIS; TIME FACTOR;

BETA-LACTAMASES; ELECTROPHORESIS, GEL, PULSED-FIELD; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; ESCHERICHIA COLI PROTEINS; GENOTYPE; HOSPITALS; HUMANS; MICROBIAL SENSITIVITY TESTS; MOLECULAR EPIDEMIOLOGY; MULTILOCUS SEQUENCE TYPING; PHYLOGENY; PORTUGAL; TIME FACTORS;

EID: 84946546495     PISSN: 17460913     EISSN: 17460921     Source Type: Journal    
DOI: 10.2217/fmb.15.38     Document Type: Article

References (26)

1. Nicolas-Chanoine MH, Bertrand X, Madec JY. Escherichia coli ST131, an intriguing clonal group. Clin. Microbiol. Rev. 27(3), 543-574 (2014
2. Park SH, Byun JH, Choi SM, et a.l. Molecular epidemiology of extended-spectrum beta-lactamase-producing Escherichia coli in the community and hospital in Korea: emergence of ST131 producing CTX-M-15. BMC Infect. Dis. 12, 149 (2012
3. Manges AR, Johnson JR. Food-borne origins of Escherichia coli causing extraintestinal infections. Clin. Infect. Dis. 55(5), 712-719 (2012
4. Ewers C, Bethe A, Semmler T, Guenther S, Wieler LH. Extended-spectrum beta-lactamase-producing and AmpC-producing Escherichia coli from livestock and companion animals, and their putative impact on public health: a global perspective. Clin. Microbiol. Infect. 18(7), 646-655 (2012
5. Blanco J, Mora A, Mamani R, et a.l. National survey of Escherichia coli causing extraintestinal infections reveals the spread of drug-resistant clonal groups O25b: H4-B2-ST131, O15: H1-D-ST393 and CGA-D-ST69 with high virulence gene content in Spain. J. Antimicrob. Chemother. 66(9), 2011-2021 (2011
6. Izdebski R, Baraniak A, Fiett J, et a.l. Clonal structure, extended-spectrum beta-lactamases, and acquired AmpC-type cephalosporinases of Escherichia coli populations colonizing patients in rehabilitation centers in four countries. Antimicrob. Agents Chemother. 57(1), 309-316 (2013
7. Peirano G, Van Der Bij AK, Gregson DB, Pitout JD. Molecular epidemiology over an 11 year period (2000 to 2010) of extended-spectrum beta-lactamase-producing Escherichia coli causing bacteremia in a centralized Canadian region. J. Clin. Microbiol. 50(2), 294-299 (2012
8. Matsumura Y, Yamamoto M, Nagao M, et a.l. Emergence and spread of B2-ST131-O25b, B2-ST131-O16 and D-ST405 clonal groups among extended-spectrum-beta-lactamase-producing Escherichia coli in Japan. J. Antimicrob. Chemother. 67(11), 2612-2620 (2012
9. Machado E, Coque TM, Cantón R, et a.l. High diversity of extended-spectrum beta-lactamases among clinical isolates of Enterobacteriaceae from Portugal. J. Antimicrob. Chemother. 60(6), 1370-1374 (2007
10. Mendonça N, Leitão J, Manageiro V, Ferreira E, Caniça M. Spread of extended-spectrum beta-lactamase CTX-M-producing Escherichia coli clinical isolates in community and nosocomial environments in Portugal. Antimicrob. Agents Chemother. 51(6), 1946-1955 (2007
11. Rodrigues C, Machado E, Montenegro C, Peixe L, Novais Â. High diversity of extended-spectrum beta-lactamases among clinical isolates of Escherichia coli from Portugal. Presented at: 22nd European Congress of Clinical Microbiology and Infectious Diseases. London, UK, 31 March-3 April 2012
12. Clinical and Laboratory Standards Institute. Performance Standards for Antimicrobial Susceptibility Testing: Tweenty-first Informational Supplement. CLSI document M100-S21. PA, USA (2011
13. Novais Â, Pires J, Ferreira H, et a.l. Characterization of globally spread Escherichia coli ST131 isolates (1991 to 2010). Antimicrob. Agents Chemother. 56(7), 3973-3976 (2012
14. Sousa C, Novais Â, Magalhães A, Lopes J, Peixe L. Diverse high-risk B2 and D Escherichia coli clones depicted by Fourier transform infrared spectroscopy. Sci. Rep. 3, 3278 (2013
15. University of Warwick. MLST Databases at UoW. http://mlst.ucc.ie/mlst/dbs/Ecoli
16. PHYLOViZ. www.phyloviz.net/wiki/
17. Pires J, Rodrigues C, Campainha R, et a.l. ESBL-producing E. coli and K. pneumoniae: is the community a reservoir of widespread clones or clonal variants?. Presented at: 24th European Congress of Clinical Microbiology and Infectious Diseases. Barcelona, Spain, 10-13 May 2014
18. Novais Â, Rodrigues C, Pires J, Peixe L. Comparison of Escherichia coli ST131 H30 subclone with other ST131 variants and B2-non-ST131 isolates. Presented at: 24th European Congress of Clinical Microbiology and Infectious Diseases. Barcelona, Spain, 10-13 May 2014
19. Peirano G, Asensi MD, Pitondo-Silva A, et a.l. Molecular characteristics of extended-spectrum β-lactamase-producing Escherichia coli from Rio De Janeiro, Brazil. Clin. Microbiol. Infect. 17(7), 1039-1043 (2011
20. Rodriguez-Bano J, Mingorance J, Fernandez-Romero N, et a.l. Virulence profiles of bacteremic extended-spectrum beta-lactamase-producing Escherichia coli: association with epidemiological and clinical features. PLoS ONE 7(9), e44238 (2012
21. Liebana E, Carattoli A, Coque TM, et a.l. Public health risks of enterobacterial isolates producing extended-spectrum beta-lactamases or AmpC beta-lactamases in food and food-producing animals: an EU perspective of epidemiology, analytical methods, risk factors, and control options. Clin. Infect. Dis. 56(7), 1030-1037 (2013
22. Ewers C, Bethe A, Stamm I, et a.l. CTX-M-15-D-ST648 Escherichia coli from companion animals and horses: another pandemic clone combining multiresistance and extraintestinal virulence?. J. Antimicrob. Chemother. 69(5), 1224-1230 (2014
23. Hu YY, Cai JC, Zhou HW, et a.l. Molecular typing of CTX-M-producing Escherichia coli isolates from environmental water, swine feces, specimens from healthy humans, and human patients. Appl. Environ. Microbiol. 79(19), 5988-5996 (2013
24. Oteo J, Diestra K, Juan C, et a.l. Extended-spectrum beta-lactamase-producing Escherichia coli in Spain belong to a large variety of multilocus sequence typing types, including ST10 complex/A, ST23 complex/A and ST131/B2. Int. J. Antimicrob. Agents 34(2), 173-176 (2009
25. Mushtaq S, Irfan S, Sarma JB, et a.l. Phylogenetic diversity of Escherichia coli strains producing NDM-type carbapenemases. J. Antimicrob. Chemother. 66(9), 2002-2005 (2011
26. Valverde A, Cantón R, Garcillan-Barcia MP, et a.l. Spread of bla (CTX-M-14) is driven mainly by IncK plasmids disseminated among Escherichia coli phylogroups A, B1, and D in Spain. Antimicrob. Agents Chemother. 53(12), 5204-5212 (2009